MOXICLAV BIS DRY POWDER FOR ORAL SUSPENSION 457MG/5ML
Product details
Registration number: SIN16453P
Classification: Prescription Only
Active ingredients:
- Amoxicillin trihydrate eqv Amoxicillin
- Potassium Clavulanate diluted with Silica, colloidal hydrated (1:1) eqv. clavulanic acid
Strength:
- 400mg/5ml
- 57mg/5ml
Dosage form: POWDER, FOR SUSPENSION
Route: ORAL
Registrant: MEDOCHEMIE SINGAPORE PTE. LTD.
ATC code: J01CR02
HSA approval date: 29 March 2022
Manufacturer(s): MEDOCHEMIE LTD (FACTORY B)
Manufacturing country/countries: CYPRUS
What are the HSA registration number and classification for MOXICLAV BIS DRY POWDER FOR ORAL SUSPENSION 457MG/5ML?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN16453P
Classification: Prescription Only
What active ingredients and strength are recorded for MOXICLAV BIS DRY POWDER FOR ORAL SUSPENSION 457MG/5ML?
According to the HSA dataset updated 7 August 2026:
Active ingredients:
- Amoxicillin trihydrate eqv Amoxicillin
- Potassium Clavulanate diluted with Silica, colloidal hydrated (1:1) eqv. clavulanic acid
Strength:
- 400mg/5ml
- 57mg/5ml
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for MOXICLAV BIS DRY POWDER FOR ORAL SUSPENSION 457MG/5ML?
According to the HSA dataset updated 7 August 2026:
Dosage form: POWDER, FOR SUSPENSION
Route: ORAL
Who is the recorded registrant for MOXICLAV BIS DRY POWDER FOR ORAL SUSPENSION 457MG/5ML?
According to the HSA dataset updated 7 August 2026:
Registrant: MEDOCHEMIE SINGAPORE PTE. LTD.
Which manufacturers and countries are listed for MOXICLAV BIS DRY POWDER FOR ORAL SUSPENSION 457MG/5ML?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): MEDOCHEMIE LTD (FACTORY B)
Manufacturing country/countries: CYPRUS
Where can I look up MOXICLAV BIS DRY POWDER FOR ORAL SUSPENSION 457MG/5ML in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN16453P or the exact product name MOXICLAV BIS DRY POWDER FOR ORAL SUSPENSION 457MG/5ML. The general register link does not preselect this product.
What are the source dates for this MOXICLAV BIS DRY POWDER FOR ORAL SUSPENSION 457MG/5ML record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this MOXICLAV BIS DRY POWDER FOR ORAL SUSPENSION 457MG/5ML record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN16453P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)